Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Avaxia Names Research VP | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Avaxia Names Research VP

Hartman brings 20 years of R&D experience

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Deborah S. Hartman, Ph.D. has been appointed vice president of Research at Avaxia Biologics, Inc. Dr. Hartman is a scientist and senior executive with more than 20 years of experience leading international pharmaceutical R&D functions in multiple therapeutic areas.
 
Prior to joining the company, Dr. Hartman held a number of executive level roles at AstraZeneca, most recently as vice president of Projects in Innovative Medicines. Other positions included vice president of Respiratory & Inflammation Research UK and vice president of Lead Generation DECS, a global science and technology group supporting early-stage projects in eight disease areas across 12 R&D sites. Prior to joining AZ, Dr. Hartman spent seven years at Hoffmann-La Roche in Basel, Switzerland, as a project leader and principal scientist in nervous system diseases.
 
Barbara S. Fox, Ph.D., chief executive officer of Avaxia, said, “Debbie has a strong track record of delivering new drugs into the clinic and managing early clinical development. In addition to leading research efforts on AVX-470, Debbie will expand our pipeline of gut-targeted oral antibody therapeutics through internal efforts and external collaborations. I would also like to thank Dan Tracey, our former vice president, Research, for his many contributions to Avaxia and to wish him well in his retirement. We are grateful that Dan will continue to support Avaxia as a consultant.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics